DB
FOLD

Danske Bank’s Amicus Therapeutics FOLD Stock Holding History

Danske Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-172
Closed -$986 – 1515
2025
Q2 		$986 Sell
172
-47,203
-100% -$305K ﹤0.01% 1423
2025
Q1 		$387K Sell
47,375
-129,108
-73% -$1.19M ﹤0.01% 894
2024
Q4 		$1.66M Buy
176,483
+61,406
+53% +$638K 0.01% 730
2024
Q3 		$1.23M Buy
+115,077
New +$1.25M ﹤0.01% 782

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Danske Bank's FOLD Position: Q3 2025 in Review

Danske Bank sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 172 shares — an estimated $986 sold.

Danske Bank first reported a position in FOLD in Q3 2024 and held it in 4 quarters. The position peaked at $1.66M in Q4 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Danske Bank reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Danske Bank sold 172 Amicus Therapeutics shares in Q3 2025, an estimated $986.
  • Danske Bank first reported a position in Amicus Therapeutics in Q3 2024 and held it in 4 quarters.
  • Danske Bank's Amicus Therapeutics position peaked at $1.66M in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Danske Bank's 13F filing for Q3 2025, filed 13 Nov 2025.